Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Carl June
Biotech
BMS-backed Dispatch unveils with $216M, Carl June as cofounder
Dispatch's two-pronged approach has clearly impressed investors. Since 2022, the biotech has raised $216 million in both seed and series A money.
Gabrielle Masson
Jul 23, 2025 6:30am
Carl June, Vertex execs among 2024's Breakthrough Prize winners
Sep 15, 2023 8:00am
Epitope edited CAR-Ts show ability to target all blood cancers
Sep 1, 2023 9:00am
A CAR-T cell gel kills residual cancer cells after surgery
Jan 20, 2023 9:35am
Carl June's latest CAR-T work taps llamas for GI cancers
Mar 29, 2022 9:00am
Tmunity stops solid tumor CAR-T trial after 2 patients die
Jun 3, 2021 8:40am
